## 3 Results
\begin{table}
\begin{tabular}{l l l} \hline \hline  & **SCZ** & **HCs** \\ \hline PANSS–negative symptoms & r = 0.211, \(p\) = 0.031 \({}^{\text{a}}\) & - \\ \hline CDSS–depressive symptoms & r = 0.026, \(p\) = 0.787 & - \\ \hline SOFAS–social and occupational functioning & r = \(-\)0.133, \(p\) = 0.170 & - \\ \hline \hline \end{tabular}
\end{table} 
Table 4: Bivariate correlations of CRP levels with clinical manifestation and cognitive performance. \begin{table} \begin{tabular}{l l l l l l} \hline \hline  & **D-SCZ**, & **ND-SCZ**, & **HCs,** & **p** & **Significant Differences** \\  & **n = 39** & **n = 73** & **n = 55** & **p** & **between Specific Groups** \\ \hline HOMA-IR & 6.8 \(\pm\) 13.6 & 4.4 \(\pm\) 5.6 & 2.1 \(\pm\) 1.3 & \textless{}0.001 & 1 \(>\) 3, 2 \(>\) 3 \\ \hline LDL, mg/dL & 114.2 \(\pm\) 33.3 & 109.5 \(\pm\) 33.5 & 110.1 \(\pm\) 30.9 & 0.966 & - \\ \hline Total cholesterol, mg/dL & 197.1 \(\pm\) 49.5 & 196.1 38.9 & 187.1 \(\pm\) 34.9 & 0.344 & - \\ \hline HDL, mg/dL & 45.9 \(\pm\) 14.2 & 50.7 \(\pm\) 12.7 & 57.9 \(\pm\) 15.8 & \textless{}0.001 & 1 \(<\) 3, 2 \(<\) 3 \\ \hline non-HDL, mg/dL & 152.8 \(\pm\) 49.4 & 144.4 \(\pm\) 44.4 & 130.4 \(\pm\) 34.8 & 0.063 & - \\ \hline Triglycerides, mg/dL & 176.0 \(\pm\) 130.9 & 165.7 \(\pm\) 82.6 & 113.9 \(\pm\) 57.8 & \textless{}0.001 & 1 \(>\) 3, 2 \(>\) 3 \\ \hline CRP, mg/L & 3.2 \(\pm\) 2.6 & 1.9 \(\pm\) 1.5 & 1.4 \(\pm\) 1.3 & \textless{}0.001 & 1 \(>\) 2, 1 \(>\) 3 \\ \hline \hline \end{tabular}  \ \begin{tabular}{l l l l l} \hline \hline  & **D-SCZ** & **ND-SCZ**, & **HCs,** & **p** & **Significant Differences** \\  & **n = 39** & **n = 73** & **n = 55** & **p** & **between Specific Groups** \\ \hline HOMA-IR & 6.8 \(\pm\) 13.6 & 4.4 \(\pm\) 5.6 & 2.1 \(\pm\) 1.3 & \textless{}0.001 & 1 \(>\) 3, 2 \(>\) 3 \\ \hline LDL, mg/dL & 114.2 \(\pm\) 33.3 & 109.5 \(\pm\) 33.5 & 110.1 \(\pm\) 30.9 & 0.966 & - \\ \hline Total cholesterol, mg/dL & 197.1 \(\pm\) 49.5 & 196.1 38.9 & 187.1 \(\pm\) 34.9 & 0.344 & - \\ \hline HDL, mg/dL & 45.9 \(\pm\) 14.2 & 50.7 \(\pm\) 12.7 & 57.9 \(\pm\) 15.8 & \textless{}0.001 & 1 \(<\) 3, 2 \(<\) 3 \\ \hline non-HDL, mg/dL & 152.8 \(\pm\) 49.4 & 144.4 \(\pm\) 44.4 & 130.4 \(\pm\) 34.8 & 0.063 & - \\ \hline Triglycerides, mg/dL & 176.0 \(\pm\) 130.9 & 165.7 \(\pm\) 82.6 & 113.9 \(\pm\) 57.8 & \textless{}0.001 & 1 \(>\) 3, 2 \(>\) 3 \\ \hline CRP, mg/L & 3.2 \(\pm\) 2.6 & 1.9 \(\pm\) 1.5 & 1.4 \(\pm\) 1.3 & \textless{}0.001 & 1 \(>\) 2, 1 \(>\) 3 \\ \hline \hline \end{tabular} 
\begin{tabular}{l l l l l} \hline \hline  & **DOMA-IR** & **HDL** & **Triglycerides** & **CRP** \\ \hline Group & F = 0.510, \(p\) = 0.602 & F = 2.721, \(p\) = 0.070 & F = 0.248, \(p\) = 0.781 & F = **3.277, \(p\) = 0.041** \\ \hline BMI & **F = 14.372, \(p\) < 0.001** & F = 1.584, \(p\) = 0.210 & F = 3.838, \(p\) = 0.052 & F = **11.741, \(p\) < 0.001** \\ \hline FTND & **F = 5.731, \(p\) = 0.018** & **F = 6.590, \(p\) = 0.011** & **F = 8.854, \(p\) = 0.003** & F = 2.189, \(p\) = 0.141 \\ \hline aMED & F = 0.984, \(p\) = 0.323 & F = 5.617, \(p\) = 0.019 & F = 0.597, \(p\) = 0.441 & F = 0.500, \(p\) = 0.481 \\ \hline Total PA & F = 3.920, \(p\) = 0.050 & F = 2.679, \(p\) = 0.104 & F = 1.975, \(p\) = 0.162 & F = 0.053, \(p\) = 0.